News

Removal of Ranitidine from Market
Removal of Ranitidine from Market

The Food and Drug Administration (FDA) recently announced a request for manufacturers to remove all…

Apr 15, 2020
First-Time Generic Release of Vimovo
First-Time Generic Release of Vimovo

The generic equivalent of Vimovo (naproxen/esomeprazole) is now available. Vimovo is FDA approved for the…

Mar 09, 2020
FDA Releases Warning Regarding Gabapentin and Pregabalin
FDA Releases Warning Regarding Gabapentin and Pregabalin

The FDA recently released a warning for the medications, gabapentin (Neurontin, Gralise, Horizant) and pregabalin…

Dec 23, 2019
FDA Alert Concerning Ranitidine Products
FDA Alert Concerning Ranitidine Products

By: Heidi Dufrene, Pharmacy Director Earlier this month, the U.S. Food and Drug Administration (FDA)…

Sep 25, 2019
  • This field is for validation purposes and should be left unchanged.


Filter Articles

Should a claimant need this much pain medication for this long? Are claimants utilizing medications or selling on the black market?

The prevalence of opioid use and abuse among those with chronic pain has developed into one of the most pressing issues today. Download the white paper to learn facts about the opioid crisis and possible solutions to avoid prescriptions that could lead to abuse.

Download Now